Accounts Submission


HEALOME THERAPEUTICS LTD

Company Registration Number:
13123884 (England and Wales)

Unaudited abridged accounts for the year ended 31 January 2022

Period of accounts

Start date: 11 January 2021

End date: 31 January 2022

HEALOME THERAPEUTICS LTD

Contents of the Financial Statements

for the Period Ended 31 January 2022

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

HEALOME THERAPEUTICS LTD

Company Information

for the Period Ended 31 January 2022




Registered office: Birmingham Research Park
97 Vincent Drive
Birmingham
England
B15 2SQ
Company Registration Number: 13123884 (England and Wales)

HEALOME THERAPEUTICS LTD

Balance sheet

As at 31 January 2022


Notes
13 months to
31 Jan 2022
£
Fixed assets
Tangible assets: 4 1,909
Total fixed assets: 1,909
Current assets
Debtors: 78,398
Cash at bank and in hand: 51,803
Total current assets: 130,201
Creditors: amounts falling due within one year: 5 ( 5,491 )
Net current assets (liabilities): 124,710
Total assets less current liabilities: 126,619
Total net assets (liabilities): 126,619

The notes form part of these financial statements

HEALOME THERAPEUTICS LTD

Balance sheet continued

As at 31 January 2022


Notes
13 months to
31 Jan 2022
£
Capital and reserves
Called up share capital: 150,708
Profit and loss account: ( 24,089 )
Shareholders funds: 126,619

For the year ending 31 January 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 29 September 2022
And Signed On Behalf Of The Board By:

Name: Richard Williams
Status: Director

The notes form part of these financial statements

HEALOME THERAPEUTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2022

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Tangible fixed assets depreciation policy

    Tangible fixed assets are recognised at cost. Laboratory equipment is depreciated over 5 years and IT equipment is depreciated over 3 years.

HEALOME THERAPEUTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2022

  • 2. Employees

    13 months to
    31 Jan 2022
    Average number of employees during the period 1

HEALOME THERAPEUTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2022

  • 3. Off balance sheet disclosure

    No

HEALOME THERAPEUTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2022

4. Tangible Assets

Total
Cost £
Additions 1,909
Disposals -
Revaluations -
Transfers -
At 31 January 2022 1,909
Depreciation
Charge for year -
On disposals -
Other adjustments -
At 31 January 2022 -
Net book value
At 31 January 2022 1,909

HEALOME THERAPEUTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2022

5. Creditors: amounts falling due within one year note

Includes Directors loan account of £3,760. The loan is repayable on demand. No interest is chargeable.

HEALOME THERAPEUTICS LTD

Notes to the Financial Statements

for the Period Ended 31 January 2022

6.1. Loans to Directors

Name of director receiving advance or credit: Richard Williams
Description of the transaction:
The Directors loan is from one director and no interest is accruing on the loan. The loan is repayable on demand.
Advances or credits made: 3,760
Balance at 31 January 2022 3,760